Finally, ARID2 mutations, which disrupt the SWI/SNF chromatin remodeling complex, and gain-of-function mutations in the RTK-RAS-MAPK pathway were enriched specifically in squamous cell carcinomas. This evidence concerns the gene SMARCA1 and squamous cell carcinoma.